• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by QT Imaging Holdings Inc.

    11/14/24 4:01:08 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $QTI alert in real time by email
    SC 13G 1 form_sc13g_qtimagingholdings.htm


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No. )*

    QT Imaging Holdings, Inc.
    (Name of Issuer)

    Common Stock, par value $0.0001 per share
    (Title of Class of Securities)

    746962109
    (CUSIP Number)

    September 30, 2024
    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)
    ☐ Rule 13d-1(c)
    ☐ Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    CUSIP No.: 746962109
     
     
     
     
    1
    NAME OF REPORTING PERSON
    Lynrock Lake LP
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐
    (b) ☐
    3
    SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
    1,920,721
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    1,920,721
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,920,721
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    9.0% (1)
    12
    TYPE OF REPORTING PERSON
    PN, IA
    (1) Based on 21,441,416 shares of Common Stock of QT Imaging Holdings, Inc. (the “Issuer”) outstanding as of September 20, 2024, as reported in the Issuer's Prospectus Supplement filed with the Securities and Exchange Commission (“SEC”) on September 20, 2024.

    CUSIP No.: 746962109
     
     
     
     
    1
    NAME OF REPORTING PERSON
    Lynrock Lake Partners LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐
    (b) ☐
    3
    SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
    1,920,721
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    1,920,721
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,920,721
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    9.0% (1)
    12
    TYPE OF REPORTING PERSON
    OO, HC
    (1) Based on 21,441,416 shares of Common Stock of the Issuer outstanding as of September 20, 2024, as reported in the Issuer's Prospectus Supplement filed with the SEC on September 20, 2024.

    CUSIP No.: 746962109
     
     
     
     
    1
    NAME OF REPORTING PERSON
    Cynthia Paul
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐
    (b) ☐
    3
    SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
    1,920,721
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    1,920,721
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,920,721
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    9.0% (1)
    12
    TYPE OF REPORTING PERSON
    IN, HC
    (1) Based on 21,441,416 shares of Common Stock of the Issuer outstanding as of September 20, 2024, as reported in the Issuer's Prospectus Supplement filed with the SEC on September 20, 2024.

    CUSIP No.: 746962109
     
     
     
    ITEM 1(a).
    NAME OF ISSUER:
     
     
     
    QT Imaging Holdings, Inc. (the “Issuer”)
     
     
    ITEM 1(b).
    ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
     
     
     
    3 Hamilton Landing, Suite 160
    Novato, CA 94949
     
     
    ITEM 2(a).
    NAME OF PERSON FILING:
     
     
     
    Lynrock Lake LP
    Lynrock Lake Partners LLC
    Cynthia Paul
     
     
    ITEM 2(b).
    ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
     
     
     
    2 International Drive, Suite 130
    Rye Brook, NY 10573
     
     
    ITEM 2(c).
    CITIZENSHIP:
     
     
     
    Lynrock Lake LP - Delaware
    Lynrock Lake Partners LLC - Delaware
    Cynthia Paul - United States
     
     
    ITEM 2(d).
    TITLE OF CLASS OF SECURITIES:
     
     
     
    Common Stock, par value $0.0001 per share (“Common Stock”)
     
     
    ITEM 2(e).
    CUSIP NUMBER:
     
     
     
    746962109

    ITEM 3.
    IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A:
     
     
     
    (a) ☐ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c);
     
     
     
    (b) ☐ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
     
     
     
    (c) ☐ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
     
     
     
    (d) ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
     
     
     
    (e) ☒ An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
     
     
     
    (f) ☐ An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
     
     
     
    (g) ☒ A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
     
     
     
    (h) ☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     
     
     
    (i) ☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     
     
     
    (j) ☐ A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);
     
     
     
    (k) ☐ Group, in accordance with 240.13d-1(b)(1)(ii)(K).
     
     
    ITEM 4.
    OWNERSHIP:
     
     
     
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
     
     
     
     
    (a)
    Amount beneficially owned as of September 30, 2024:
     
     
    Lynrock Lake LP - 1,920,721
    Lynrock Lake Partners LLC - 1,920,721
    Cynthia Paul - 1,920,721
     
     
     
     
    (b)
    Percent of class as of September 30, 2024:
     
     
    Lynrock Lake LP - 9.0%
    Lynrock Lake Partners LLC - 9.0%
    Cynthia Paul - 9.0%
     
     
     
     
    (c)
         Number of shares as to which the person has:
     
     
     
     
     
    (i) Sole power to vote or to direct the vote:
     
     
    Lynrock Lake LP - 1,920,721
    Lynrock Lake Partners LLC - 1,920,721
    Cynthia Paul - 1,920,721
     
     
     
     
     
    (ii) Shared power to vote or to direct the vote:
     
     
    Lynrock Lake LP - 0
    Lynrock Lake Partners LLC - 0
    Cynthia Paul - 0
     
     
     
     
     
    (iii) Sole power to dispose or to direct the disposition of:
     
     
    Lynrock Lake LP - 1,920,721
    Lynrock Lake Partners LLC - 1,920,721
    Cynthia Paul - 1,920,721
     
       
     
     
    (iv) Shared power to dispose or to direct the disposition of:
     
     
    Lynrock Lake LP - 0
    Lynrock Lake Partners LLC - 0
    Cynthia Paul - 0

    As of September 30, 2024, Lynrock Lake Master Fund LP (“Lynrock Lake Master”) directly held 1,920,721 shares of the Issuer's Common Stock. In addition, as of September 30, 2024, Lynrock Lake Master directly held warrants of the Issuer that are not presently exercisable into shares of the Issuer's Common Stock due to a 4.9% beneficial ownership limitation. Lynrock Lake LP (the “Investment Manager”) is the investment manager of Lynrock Lake Master, and pursuant to an investment management agreement, the Investment Manager has been delegated full voting and investment power over securities of the Issuer held by Lynrock Lake Master. Cynthia Paul, the Chief Investment Officer of the Investment Manager and Sole Member of Lynrock Lake Partners LLC, the general partner of the Investment Manager, may be deemed to exercise voting and investment power over securities of the Issuer held by Lynrock Lake Master.

    ITEM 5.
    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
     
     
     
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.
     
     
    ITEM 6.
    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
     
     
     
    As disclosed in Item 4 of this Schedule 13G, as of September 30, 2024, Lynrock Lake Master directly held 1,920,721 shares of the Issuer's Common Stock. Certain feeder funds that invest in Lynrock Lake Master may have the right to receive dividends from, or the proceeds from the sale of, the securities directly held by Lynrock Lake Master.
     
     
    ITEM 7.
    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
     
     
     
    Not applicable.
     
     
    ITEM 8.
    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
     
     
     
    Not applicable.
       
    ITEM 9.
    NOTICE OF DISSOLUTION OF GROUP:
     
     
     
    Not applicable.
     
     
    ITEM 10.
    CERTIFICATION:
     
     
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: November 14, 2024

    LYNROCK LAKE LP
    By: Lynrock Lake Partners LLC,
    its general partner
     
     
     
     
    By:
    /s/ Cynthia Paul
     
    Name:
    Cynthia Paul
     
    Title:
    Sole Member
     
     
     
     
     
     
     
    LYNROCK LAKE PARTNERS LLC
     
     
     
     
    By:
    /s/ Cynthia Paul
     
    Name:
    Cynthia Paul
     
    Title:
    Sole Member
     
     
     
     
    /s/ Cynthia Paul
     
     
    CYNTHIA PAUL
     


    EXHIBIT 99.1

    JOINT FILING AGREEMENT

    In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G, dated November 14, 2024 (including amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of QT Imaging Holdings, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments to such joint filing and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the other.


    LYNROCK LAKE LP
    By: Lynrock Lake Partners LLC,
    its general partner
     
     
     
     
    By:
    /s/ Cynthia Paul                                          
     
    Name:
    Cynthia Paul
     
    Title:
    Sole Member
     
     
     
     
     
     
     
    LYNROCK LAKE PARTNERS LLC
     
     
     
     
    By:
    /s/ Cynthia Paul
     
    Name:
    Cynthia Paul
     
    Title:
    Sole Member
     
     
     
     
    /s/ Cynthia Paul
     
     
    CYNTHIA PAUL
     



    Get the next $QTI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QTI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $QTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    QT Imaging Holdings Introduces Machine Learning-Enabled Image Interpolation Algorithm to Substantially Reduce Scan Time

    QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QTI") a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce the release of a machine learning-enabled image interpolation algorithm designed to significantly reduce scan times by approximately 50%. This advancement is expected to enhance patient comfort by decreasing time spent on the scanner and improve operational efficiency by increasing the number of patients scanned within a given timeframe. The advanced machine learning algorithm enables sophisticated image interpolation, allowing the system to skip every other scan level while accurately preserving high imag

    1/14/25 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue Growth

    QT Imaging Holdings, Inc. (NASDAQ:QTI) (the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce strengthening of its financials, by clearing its short-term liabilities and by forecasting solid revenue growth in 2025 and 2026. The Company announced amendments to both its convertible promissory note with YA II PN, Ltd. (the "YA Investor," and such promissory note, the "YA Note") and to its convertible promissory note with Funicular Funds, LP (the "Cable Car Investor," and such promissory note, the "Cable Car Note"), each of which was entered into on January 9, 2025. With the amendments of YA

    1/13/25 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Holdings Announces New Commercial Shipment in Partnership with Couri Center

    QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce expansion of locations offering the Breast Acoustic CTTM Scanner to Couri Center for Gynecology and Integrative Women's Health, in Peoria, IL. The shipment was made together with our strategic business and distribution partner, NXC Imaging, Inc. "Our partnership with QTI marks a pivotal moment in breast imaging technology. With the QTI Breast Acoustic CTTM System, patients can experience an enhanced approach to breast imaging that prioritizes comfort and safety without compromising image quality," stated Jon Stoa,

    12/12/24 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Greene James S bought $250,000 worth of shares (428,082 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:04:44 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Dickson Daniel H bought $50,000 worth of shares (85,616 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:54 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chairman Katz Avi S bought $1,834,999 worth of shares (3,142,122 units at $0.58), increasing direct ownership by 252% to 657,960 units (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:30 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    SEC Filings

    View All

    SEC Form S-8 filed by QT Imaging Holdings Inc.

    S-8 - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

    2/12/25 4:15:47 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form EFFECT filed by QT Imaging Holdings Inc.

    EFFECT - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

    2/6/25 12:15:06 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 424B3 filed by QT Imaging Holdings Inc.

    424B3 - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

    2/5/25 4:30:33 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Greene James S bought $250,000 worth of shares (428,082 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:04:44 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Dickson Daniel H bought $50,000 worth of shares (85,616 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:54 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chairman Katz Avi S bought $1,834,999 worth of shares (3,142,122 units at $0.58), increasing direct ownership by 252% to 657,960 units (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:30 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Leadership Updates

    Live Leadership Updates

    View All

    QT Imaging Announces First Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $1.4M with 56% Gross Margin in the First Quarter of 2024, Since the Company Became Public on March 4th Streamlined Business Model via Strategic Sales and Distribution Partnership in USA Reported in Academic Radiology the Results of a Second Blinded Screening Trial That Found That QTI Technology Is Similarly Effective as Digital Breast Tomosynthesis (DBT) or 3D Mammography Company Completed Merger with GigCapital5 QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first qu

    5/10/24 8:57:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Financials

    Live finance-specific insights

    View All

    QT Imaging Announces Third Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $0.9 Million with 65% Gross Margin in the Third Quarter of 2024 The Company Successfully Completed the Engineering and Clinical Feasibility Study with its Strategic Partner The Company Announced Entering into Favorable Amendments to Its $10 Million Convertible Promissory Note with YA II PN, Ltd. The Company Announced Insiders PIPE investment of $2.56 Million, fully funded by the QTI Board of Directors members and their Affiliates QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results

    11/13/24 8:32:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Announces Second Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $1.7 Million with 51% Gross Margin in the Second Quarter of 2024 The Company Continues to Make Progress in the Engineering and Clinical Feasibility Study with its Strategic Partner Signed a U.S. Exclusive Distribution Agreement Announced Partnership with the University of Oklahoma and OU Health Stephenson Cancer Center to Improve Precision in Cancer Detection and Treatment QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the second quarter of 2024. "QT Imaging's team comp

    8/8/24 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by QT Imaging Holdings Inc.

    SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    11/22/24 4:15:11 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by QT Imaging Holdings Inc.

    SC 13G - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    11/14/24 4:01:08 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by QT Imaging Holdings Inc.

    SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    9/13/24 4:23:43 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care